Prominent physician, author and health services researcher Martin Shapiro will speak at an event on the Ithaca campus. He will describe steps to reform the health care system and lead a discussion that is open to all.
Mario Herrero, a professor in the Department of Global Development and a Cornell Atkinson Scholar, has been appointed to the EAT-Lancet 2.0 leadership team to spearhead the modeling workstream.
By teasing out the biological mechanisms in pregnancy-related mental health disorders, investigators at Weill Cornell Medicine are laying the groundwork for new ways to detect and treat pregnant women and new mothers at risk.
Research findings suggest that women who took hormones in midlife to treat their menopause symptoms were less likely to develop dementia than those who hadn’t taken estrogen.
An experimental mRNA vaccine against human cytomegalovirus, a common virus that can infect babies during pregnancy, elicited some of the most promising immune responses to date of any vaccine candidate, according to a study by Weill Cornell Medicine investigators.
By studying individuals who spontaneously clear hepatitis C infections, a team of researchers has identified viable vaccine targets for a disease that infects 70 million worldwide.
A multicenter, phase 3 clinical trial has found that apixaban is no more effective than aspirin at preventing a second stroke in patients diagnosed with a milder, related condition called atrial cardiopathy, according to new research.
The financial stability of providers and their ability to serve patients is being threatened by Wall Street, according to new research co-authored by ILR Professor Rose Batt.
Cathy Garzio, a distinguished academic medicine administrator, has been appointed executive vice provost and chief operating officer of Weill Cornell Medicine, effective early February.